RIFAMPICIN REDUCES EFFECTIVENESS AND BIOAVAILABILITY OF PREDNISOLONE

被引：180
|
作者：
MCALLISTER, WAC
THOMPSON, PJ
ALHABET, SM
ROGERS, HJ
机构：
[1] BROMPTON HOSP,LONDON SW3 6HP,ENGLAND
[2] GUYS HOSP,SCH MED,DEPT CLIN PHARMACOL,LONDON SE1 9RT,ENGLAND
来源：
BRITISH MEDICAL JOURNAL | 1983年 / 286卷 / 6369期
关键词：
D O I：
10.1136/bmj.286.6369.923
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：923 / 925
页数：3
相关论文
共 50 条
  • [41] CHANGES IN PREDNISOLONE PHARMACOKINETICS AND PROTEIN-BINDING DURING TREATMENT WITH RIFAMPICIN
    BERGREM, H
    REFVEM, OK
    PROCEEDINGS OF THE EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION, 1982, 19 : 552 - 557
  • [42] Rifampicin “markedly reduces” the plasma concentrations of aliskiren,
    Reactions Weekly, 2010, 1293 (1) : 6 - 6
  • [43] Rifampicin greatly reduces plasma concentrations of tamoxifen
    Villikka, K
    Kivistö, KT
    Nyman, L
    Anttila, M
    Neuvonen, PJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R456 - R456
  • [44] Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
    Zhu Hui
    Guo Shao-Chen
    Hao Lan-Hu
    Liu Cheng-Cheng
    Wang Bin
    Fu Lei
    Chen Ming-Ting
    Zhou Lin
    Chi Jun-Ying
    Yang Wen
    Nie Wen-Juan
    Lu Yu
    中华医学杂志英文版, 2015, 128 (04) : 433 - 437
  • [45] Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
    Zhu, Hui
    Guo, Shao-Chen
    Hao, Lan-Hu
    Liu, Cheng-Cheng
    Wang, Bin
    Fu, Lei
    Chen, Ming-Ting
    Zhou, Lin
    Chi, Jun-Ying
    Yang, Wen
    Nie, Wen-Juan
    Lu, Yu
    CHINESE MEDICAL JOURNAL, 2015, 128 (04) : 433 - 437
  • [46] Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux
    Louw, Gail E.
    Warren, Robin M.
    Gey van Pittius, Nicolaas C.
    Leon, Rosalba
    Jimenez, Adelina
    Hernandez-Pando, Rogelio
    McEvoy, Christopher R. E.
    Grobbelaar, Melanie
    Murray, Megan
    van Helden, Paul D.
    Victor, Thomas C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (02) : 269 - 276
  • [47] EFFECTIVENESS OF PREDNISOLONE DURING PHENYTOIN THERAPY
    PETEREIT, LB
    MEIKLE, AW
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1977, 22 (06) : 912 - 916
  • [48] STUDY OF THE EFFECT OF CONCOMITANT FOOD ON THE BIOAVAILABILITY OF RIFAMPICIN, ISONIAZID AND PYRAZINAMIDE
    ZENT, C
    SMITH, P
    TUBERCLE AND LUNG DISEASE, 1995, 76 (02): : 109 - 113
  • [49] The development of a standardised screening protocol for the in vivo assessment of rifampicin bioavailability
    McIlleron, H
    Gabriels, G
    Smith, PJ
    Fourie, PB
    Ellard, GA
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (11) : S329 - S335
  • [50] Bioavailability and pharmacokinetics of a new liquid prednisolone formulation in comparison with two commercially available liquid prednisolone products
    Ahmed, M
    Morrel, EM
    Clemente, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (07): : 548 - 556
12345